amounts as management deems appropriate.  The Company is not obligated to repurchase any specific number of shares, and the timing and actual number of shares repurchased will depend on a variety of factors, including the Company’s stock price, general economic, business and market conditions, and alternative investment opportunities.  The Company may discontinue any repurchases of its common stock at any time without prior notice.  During the year ended December 31, 2024, the Company repurchased
9,861,935
shares for an aggregate amount of $
6,211
million (excluding the 1% excise tax on stock repurchases as a result of the Inflation Reduction Act of 2022).  As of December 31, 2024, $
17.1
billion remains available for repurchases.  Shares repurchased by the Company are accounted for when the transaction is settled.  As of December 31, 2024, there were no unsettled share repurchases.  Direct costs incurred to acquire the shares are included in the total cost of the shares.
59
Table of Contents
Accumulated Other Comprehensive Income (Loss)
The following table summarizes the changes in accumulated balances of other comprehensive income (loss):
The following table summarizes the amounts reclassified from AOCI to the Consolidated Statement of Operations:
No
amounts were reclassified from AOCI into the Consolidated Statements of Operations in the years ended December 31, 2023 and 2022.
60
Table of Contents
10.
Income Taxes
Income before provision for income taxes was as follows:
The components of provision for income taxes for all periods presented were as follows:
A reconciliation of the provision for income taxes to the amount computed by applying the 21% statutory Federal income tax rate to income before income taxes is as follows:
61
Table of Contents
The components of deferred tax assets and liabilities were as follows:
The following table shows the deferred tax assets and liabilities within our Consolidated Balance Sheets:
As of December 31, 2024, for tax return purposes, the Company had $
694
million of California R&D tax credit carryforwards which can be carried forward indefinitely, $
943
million of state net operating loss carryforwards which will begin to expire in 2026, $
41
million of foreign tax credit carryforwards which will begin to expire in 2033, and $
420
million of foreign net operating loss carryforwards which will begin to expire in 2025.
In evaluating its ability to realize the net deferred tax assets, the Company considered all available positive and negative evidence, including its past operating results and the forecast of future market growth, forecasted earnings, future taxable income, and prudent and feasible tax planning strategies.  As of December 31, 2024, the valuation allowance of $
540
million was primarily related to California R&D tax credits, state net operating loss carryforwards, and foreign tax credits that the Company does not expect to realize.
At December 31, 2024, we have not provided for applicable U.S.